<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Epstein-Barr virus (EBV) is associated with both benign and malignant lymphoproliferative processes </plain></SENT>
<SENT sid="1" pm="."><plain>Recently, mice with <z:hpo ids='HP_0004430'>severe combined immunodeficiency</z:hpo> (<z:mp ids='MP_0002536'>SCID</z:mp>) have been described that develop EBV-induced <z:hpo ids='HP_0002665'>lymphomas</z:hpo> when inoculated with peripheral blood lymphocytes from EBV-seropositive individuals </plain></SENT>
<SENT sid="2" pm="."><plain>To investigate the pathogenesis of EBV-associated Burkitt <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, we intraperitoneally inoculated <z:mp ids='MP_0002536'>SCID</z:mp> mice with cells from EBV-infected Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) cell lines </plain></SENT>
<SENT sid="3" pm="."><plain>In general, cells from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> lines developed into <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>-like <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Certain <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cell lines, however, were not particularly tumorigenic in these animals </plain></SENT>
<SENT sid="5" pm="."><plain>Antibody capable of depleting mice of natural killer cells (anti-asialo GM1) favored the development of these Burkitt <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>The pathogenetic implications of this animal model for human disease is discussed </plain></SENT>
</text></document>